FindTrial
Sign In

A protocol to assess diabetic neuropathy patients

Assessment protocol for diabetic neuropathy patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023600
Enrollment
40
Registered
2020-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E134- Other specified diabetes mellituswith neurological complications

Interventions

None listed

Sponsors

Indhu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients having diabetic and diabetic neuropathy, able to walk independently, both type1 and type2 diabetes.

Exclusion criteria

Exclusion criteria: any neurological, muscle or rheumatic disease, foot ulcer/foot amputation

Design outcomes

Primary

MeasureTime frame
Michigan Neuropathy Screening InstrumentTimepoint: 1st day—

Secondary

MeasureTime frame
Michigan Neuropathy Screening InstrumentTimepoint: 1st day—

Countries

India

Contacts

Public ContactIndhu

Guide

radhikashuba@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026